4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0001209191-03-033820
Chief Executive Officer sold 255,000 shares at an average $0.17 ($42,240)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANDELL HENRY R Chief Executive Officer | 2003-11-28 | Sale | −30,000 | $0.21 | $6,150 | 1,949,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-11-28 | Sale | −10,000 | $0.20 | $2,000 | 1,949,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-11-28 | Sale | −7,000 | $0.21 | $1,470 | 1,949,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-11-28 | Sale | −10,000 | $0.17 | $1,700 | 1,949,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −10,000 | $0.20 | $2,000 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −15,000 | $0.19 | $2,850 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −30,000 | $0.19 | $5,550 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −45,000 | $0.16 | $6,975 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −5,000 | $0.16 | $800 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −5,000 | $0.15 | $725 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −5,000 | $0.15 | $770 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −10,000 | $0.18 | $1,800 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −23,000 | $0.15 | $3,450 | 1,851,572 | D |
| MANDELL HENRY R Chief Executive Officer | 2003-12-01 | Sale | −50,000 | $0.12 | $6,000 | 1,851,572 | D |
| Open-market sales · 255,000 sh · avg $0.17 · $42,240 | |||||||
Loading xslF345X02/bcc95039_bcc1.xml…